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Abstract
This report suggests that self-resolving oligohydramnios is an early sign of malfunctioning kidney in individuals with renal coloboma syndrome (RCS) and
demonstrates how a genetic diagnosis can impact patient and fetal management
as it outlines two generations of RCS.
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I N T RO DU CT ION

Renal coloboma syndrome (RCS) is an autosomal dominant disorder with high penetrance and variable expressivity.1 RCS is primarily characterized by renal dysplasia
and abnormalities of the optic nerve.1,2
Although there are no formal diagnostic criteria for
RCS, it is thought to be associated with a heterozygous
pathogenic variant in PAX2.1 50% of patients with clinical
findings suggestive of RCS (eg, renal and ocular malformations) have a variant in the PAX2 gene.2 As a result of
improved access to molecular genetic testing, more individuals with PAX2 variants have been identified with a
wide phenotypic variability.

Renal and ocular findings are reported in 92% and
72% of affected individuals, respectively.1 Abnormalities
in kidney structure and function are among the most
frequent findings in individuals with PAX2 variants,
which include renal dysplasia, multicystic dysplastic
kidney, and end-
stage renal disease. Primary ocular
findings involve optic nerve dysplasia that ranges from
severe to mild.1,2
Reports of prenatal RCS findings have been limited,
highlighting the importance of intrafamilial monitoring
among affected individuals. Once a PAX2 pathogenic
variant has been identified in a family, prenatal genetic
testing for the familial variant becomes possible, in addition to screening through ultrasound (US), to detect
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any renal malformations and assess amniotic fluid levels.1 To date, only six case reports and one large series
have been published on prenatal RCS findings.3-8 Of the
six case reports, four involved terminated pregnancies as
a result of prenatal US findings of fetal renal dysplasia
and/or oligohydramnios.3-5 Common findings among
all case reports include bilateral fetal renal hypoplasia
and observed bilateral optic disc colobomas postnatally.
Upon genetic testing, there is considerable variability in
the PAX2 gene variants, with most case reports having a
de novo variant.4,5,7,8 Notably, one case report presents a
male with moderate-severe oligohydramnios for which
an amnio-infusion of 250 ml of normal saline was performed. The remainder of the pregnancy was monitored
with serial US examinations, leading to a live birth following that intervention.3 Bower et al reported one of
the biggest RCS prenatal case series that added 13 prenatal cases to the literature.9 Six of the 13 fetuses were
terminated given prenatal findings of renal hypoplasia,
in addition to severe oligohydramnios. All six cases had
parents confirmed with a pathogenic PAX2 variant. The
other seven surviving cases had de novo variants. Five
out of the seven had normal amniotic fluid levels, while
the other two had mild oligohydramnios, in addition to
a renal hypoplasia or dysplasia. None of the 13 cases reviewed had self-resolving oligohydramnios.
We further add to the literature a report of mother and
her newborn with RCS, both presenting prenatally with
self-resolving severe oligohydramnios as an early prenatal
finding.
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CASE

The proband was a 27-year-old primigravida who was
referred to the Maternal Fetal Medicine (MFM) clinic
given a personal history of obesity and chronic renal disease post-transplant. She was seen at 16 weeks and 1 day
gestation with findings of severe oligohydramnios on a viability US. (Figure 1A). A limited survey of the anatomy

(A)

was attempted during which the bladder and fetal kidneys
were not well visualized due to the low amniotic fluid,
large maternal body habitus, and the early gestational age.
The patient denied any symptoms of vaginal fluid loss
and had no known exposure to teratogens or any relevant
medications (eg, NSAIDs or ACE inhibitors).
The patient's medical history was remarkable as she
was personally induced near term, given early prenatal
history of anhydramnios that “normalized” as reported by
her mother. She was subsequently diagnosed with a solitary dysplastic left kidney. She had a right ureteropelvic
junction (UPJ) obstruction and a progressive segmental
sclerosis, leading to end-stage renal disease at 20 years of
age. As such, she required a kidney transplant the year
prior to this pregnancy.
A three-generation pedigree was reviewed. Our patient
was the second child born to non-consanguineous couple
of Irish and French-Canadian descent. Her older sibling
had 3 healthy children and terminated a pregnancy with
an isolated hypoplastic left heart. Her partner is one of
three healthy siblings of English and Dutch background.
A follow-up with the multi-disciplinary clinic (MFM,
NICU, and Genetics) was planned with a repeat US
performed at 18+5 weeks gestation, again showing severe oligohydramnios with a maximum vertical pocket
of 1.1 cm. The bladder was visualized, but the kidneys
and renal arteries were not clearly seen. There were no
anomalies identified in that US, and growth was found
to be adequate for the given gestational age. The couple
was counseled by the team on the likely poor perinatal
prognosis given the severe oligohydramnios in the mid-
trimester and its association with pulmonary hypoplasia.
Prenatal investigation options were discussed, and a pregnancy termination option was presented with early induction, postnatal autopsy, and testing. The couple opted
for expected management and was well aware of the high
likelihood of poor perinatal outcomes and the need for
close follow-up.
The fetal kidney and renal artery were seen in a repeat
US at 21 weeks gestation and appeared grossly normal

(B)

F I G U R E 1 A, Antenatal ultrasound
image at 16 weeks and 1 day gestation
showing a transverse view of the uterus
with severe oligohydramnios. B, Antenatal
ultrasound image at 36 weeks gestation
showing normal amniotic fluid with a
maximum vertical pocket of 6.89 cm
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despite being on the smaller size. Subsequent biweekly US
showed gradual improvement of fluid levels.
Given her medical history and constellation of features,
the patient was offered a Congenital Abnormalities of
the Kidney and Urinary Tract (CAKUT) next-generation
sequencing panel, which revealed a pathogenic variant involving the PAX2 gene described as c.76dup: p.
Val26Glyfs*28: NM_003990.4. This is responsible for the
clinical condition of RCS, also described as a PAX2-related
disorder.
The timing of the results coincided with a repeat US
at 36 weeks in which amniotic fluid levels normalized
(Figure 1B). Around that time, our patient started experiencing abnormal vision in the context of a headache.
Recognizing the ocular spectrum of RCS, this prompted
an urgent ocular assessment. Dilated fundus examination
of both eyes revealed no retinal tears or detachments. No
ocular coloboma was observed; however, there was vitreous syneresis and dilated vessels in the right eye. Ocular
follow-up was recommended, given the RCS diagnosis and
risk for future eye concerns. Knowing RCS’s autosomal
dominant inheritance, that diagnosis was suspected for
the baby. Postnatal kidney US and eye examination were
planned for the newborn, in addition to targeted testing
for the PAX2 variant.
The amniotic fluid levels had normalized in the beginning of the third trimester and remained in a similar range
up to the time of delivery. The patient was induced at
37 weeks and 2 days gestation and had a baby girl weighing 7 pounds 11 ounces via an emergent cesarean section.
The baby's eye examination was normal. Her bloodwork
showed slightly elevated serum creatinine, partially reflecting maternal serum creatinine, age-appropriate estimated glomerular filtration rate, some albuminuria,
and no concern about hypertension or pulmonary hypoplasia. Her kidneys were normal in morphology on US,
with a lower end of measurement for her age. Genetic
testing confirmed the maternal PAX2 variant. Upon a recent check-up, the almost 2-year-old girl had stable mild
albuminuria with echogenic kidneys based on US, with
suspected bilateral renal dysplasia, and continues to be
monitored by nephrology.
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DI S C USSION / CON CLU SIO N

Our case provides further evidence that oligohydramnios is an early US sign of malfunctioning kidneys in a
fetus affected with RCS. Both the mother and her child
were affected, and we saw that the low levels of amniotic
fluid throughout the second trimester indicated kidney
malfunction, despite renal structure initially appearing
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grossly normal as seen in the baby girl. For both patients,
the amniotic fluid volume normalized in the early third
trimester without intervention. Given the maternal personal history, the couple elected to continue their pregnancy as they were confident that the fluid levels would
normalize and pulmonary insufficiency seemed unlikely.
With this decision, we were able to document a two-
generation history of self-resolving oligohydramnios as an
early US sign of RCS.
We described earlier how RCS is known to be associated with a heterozygous pathogenic PAX2 variant.
During embryonic development, the PAX2 gene is involved with the formation of many organs, including the
developing kidneys. Debhi et al described the PAX2 gene's
role during the mesenchymal-to-epithelial transition in
renal development.10 To date, most cases flagged prenatally were identified due to renal hypoplasia secondary to
PAX2 mutations.
Renal insufficiency and end-
stage renal disease
(ESRD) without hypoplasia have been described by
Bower et al, with the mean age at ESRD diagnosis
in PAX2-related conditions being 19.5 years.1 This age at
diagnosis ranged from birth to 79 years. We propose that
in our patient, the oligohydramnios was an early sign of
renal malfunction. In the absence of renal hypoplasia,
progressive increase in kidney size compensates for the
malfunctioning podocytes, which resulted in a transient
oligohydramnios.
This case also highlights how an RCS diagnosis
through the CAKUT sequencing panel has impacted management for the mother who required an eye examination
prior to her delivery. This molecular diagnosis prompted
the nephrology team to closely monitor the newborn girl.
Through this monitoring, we were able to see early signs
of renal failure in the baby girl, with suspected bilateral
kidney dysplasia on postnatal US, not noted until recently
at almost 2 years of age.
Given the mother's RCS diagnosis and past medical,
obstetrical, and surgical history, it puts her at high risk
for obstetrical care. Shortly after giving birth, the mother
returned to the high-risk obstetrical clinic with her second pregnancy. Amniotic fluid levels were always normal
in that subsequent pregnancy. Reassured, the couple deferred molecular testing for the PAX2 variant until after
delivery. The mother was able to successfully, without
complication, deliver a second daughter who was not affected by the PAX2 variant.
In this case, the collection of a detailed medical and
family history, and subsequent genetic analysis related
to the patient's history, led to a better understanding of
the US anomalies seen during pregnancy and greatly impacted neonatal care.
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What is Already Known About
This Topic?

What Does This Study
Add?

• There are no publications
linking prenatally detected
severe oligohydramnios that
self-corrects upon birth in RCS
patients.

• We report two
generations of RCS,
flagged prenatally,
with resolving severe
oligohydramnios.
• This report suggests
that self-resolving
oligohydramnios
is an early sign of
malfunctioning kidney
in RCS individuals
and demonstrates how
a genetic diagnosis
impacted patient
management.
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